Bioceres Crop Solutions (NASDAQ:BIOX) Given New $16.00 Price Target at Oppenheimer

Bioceres Crop Solutions (NASDAQ:BIOX) had its price objective reduced by investment analysts at Oppenheimer from $17.00 to $16.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Oppenheimer’s target price would suggest a potential upside of 84.97% from the stock’s current price.

A number of other brokerages have also issued reports on BIOX. Canaccord Genuity Group upgraded shares of Bioceres Crop Solutions to a “strong-buy” rating in a research report on Friday, July 19th. Lake Street Capital reduced their price objective on Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating on the stock in a report on Wednesday. Roth Capital upgraded Bioceres Crop Solutions to a “strong-buy” rating in a research report on Tuesday, July 2nd. Canaccord Genuity Group restated a “buy” rating and set a $17.00 target price on shares of Bioceres Crop Solutions in a research report on Friday, July 19th. Finally, Roth Mkm began coverage on Bioceres Crop Solutions in a report on Tuesday, July 2nd. They issued a “buy” rating and a $15.00 price target on the stock. Four equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $15.25.

Bioceres Crop Solutions Trading Down 13.4 %

BIOX stock opened at $8.65 on Wednesday. The business has a fifty day moving average price of $10.59 and a 200 day moving average price of $11.50. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.22 and a quick ratio of 0.83. Bioceres Crop Solutions has a fifty-two week low of $8.42 and a fifty-two week high of $14.05. The stock has a market capitalization of $543.22 million, a price-to-earnings ratio of 865.00 and a beta of 0.49.

Bioceres Crop Solutions (NASDAQ:BIOX) last announced its earnings results on Monday, September 9th. The company reported ($0.03) earnings per share for the quarter, missing analysts’ consensus estimates of $0.20 by ($0.23). The business had revenue of $124.30 million during the quarter, compared to analyst estimates of $126.75 million. Bioceres Crop Solutions had a net margin of 0.21% and a return on equity of 0.28%. During the same quarter last year, the business posted ($0.06) earnings per share. Analysts expect that Bioceres Crop Solutions will post 0.3 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. Activest Wealth Management acquired a new stake in shares of Bioceres Crop Solutions during the first quarter worth $30,000. Cape Investment Advisory Inc. bought a new position in Bioceres Crop Solutions during the fourth quarter worth about $33,000. Oppenheimer & Co. Inc. acquired a new position in shares of Bioceres Crop Solutions during the 1st quarter worth about $139,000. Lazard Asset Management LLC bought a new stake in shares of Bioceres Crop Solutions in the 1st quarter valued at about $212,000. Finally, Ping Capital Management Inc. acquired a new stake in shares of Bioceres Crop Solutions in the 2nd quarter valued at approximately $448,000. Institutional investors and hedge funds own 17.68% of the company’s stock.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.